These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2138086)

  • 1. Receptor-mediated stimulation of taurocholate efflux from the rat hepatocyte and the ex vivo perfused rat liver.
    Kuhn WF; Heuman DM; Vlahcevic ZR; Gewirtz DA
    Eur J Pharmacol; 1990 Jan; 175(2):117-28. PubMed ID: 2138086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of taurocholate and glycocholate efflux from the rat hepatocyte by arginine vasopressin.
    Kuhn WF; Gewirtz DA
    Am J Physiol; 1988 May; 254(5 Pt 1):G732-40. PubMed ID: 3364571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of taurocholate release from isolated rat hepatocytes in suspension by alpha-adrenergic agents and vasopressin: implications for control of bile salt secretion.
    Gewirtz DA; Randolph JK; Goldman ID
    Hepatology; 1984; 4(2):205-12. PubMed ID: 6142855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide).
    Vore M; Durham S; Yeh S; Ganguly T
    Biochem Pharmacol; 1991 Feb; 41(3):431-7. PubMed ID: 1994901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressor-type vasopressin receptors in the adrenal cortex: properties of binding, effects on phosphoinositide metabolism and aldosterone secretion.
    Balla T; Enyedi P; Spät A; Antoni FA
    Endocrinology; 1985 Jul; 117(1):421-3. PubMed ID: 2988926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery.
    Clineschmidt BV; Lis EV
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
    Stassen FL; Heckman G; Schmidt D; Nambi P; Aiyar N; Landvatter S; Crooke ST
    Mol Pharmacol; 1987 Mar; 31(3):267-72. PubMed ID: 2951585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of selective arginine vasopressin V1 and V2 receptor antagonists on burn shock in the rat.
    Sun K; Lin BC; Wang CH; Zhu HN
    Cardiovasc Res; 1991 Apr; 25(4):265-9. PubMed ID: 1884385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct identification of the rat hepatocyte arginine8 vasopressin receptor with a radiolabelled V1-selective antagonist.
    Cornett LE; Cate CM
    J Recept Res; 1989; 9(1):1-18. PubMed ID: 2915345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes.
    Kukongviriyapan V; Stacey NH
    J Pharmacol Exp Ther; 1988 Nov; 247(2):685-9. PubMed ID: 3183963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine-vasopressin stimulates the formation of phosphatidic acid in rat Leydig cells.
    Nielsen JR; Hansen HS; Jensen B
    FEBS Lett; 1987 Jun; 218(1):93-6. PubMed ID: 3036589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
    Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells.
    Jamil KM; Watanabe T; Nakao A; Okuda T; Kurokawa K
    Biochem Biophys Res Commun; 1993 Jun; 193(2):738-43. PubMed ID: 8390252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antagonists of the vasopressin receptor mediated contraction in rat tail artery.
    Petrusewicz J; Damasiewicz B; Kaliszan R; Juzwa W; Lammek B; Derdowska I
    Pharmacol Res; 1992; 25(2):167-72. PubMed ID: 1386154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Through the central V2, not V1 receptors influencing the endogenous opiate peptide system, arginine vasopressin, not oxytocin in the hypothalamic paraventricular nucleus involves in the antinociception in the rat.
    Yang J; Chen JM; Song CY; Liu WY; Wang G; Wang CH; Lin BC
    Brain Res; 2006 Jan; 1069(1):127-38. PubMed ID: 16409991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligand.
    Elands J; Barberis C; Jard S; Lammek B; Manning M; Sawyer WH; de Kloet ER
    FEBS Lett; 1988 Mar; 229(2):251-5. PubMed ID: 2964381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.